Clinical Trials for Ingrid Mayer

5 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCBREP1363
03/21/2014
A Phase Ib/II, Multicenter, Study of the Combination of LEE011 and BYL719 with Letrozole in Adult Patients with Advanced ER+ Breast Cancer
TreatmentVICCPHI1364
03/07/2014
A Phase Ib, Open-Label Study of Oral BGJ398 in Combination with Oral BYL719 in Adult Patients with Select Advanced Solid Tumors
TreatmentVICCBREP12116
03/25/2013
An Open-Label, Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
TreatmentVICCBRE1280
02/07/2013
A Phase III Randomized, Double Blind Placebo Controlled Study of BKM120 with Fulvestrant, in Postmenopausal Women with Hormone Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer Which Progressed On or After Aromatase Inhibitor Treatment
TreatmentVICCPHI1248
10/12/2012
An Open-Label, Phase I, Dose-Escalation Study Evaluating the Safety and Tolerability of GDC0032 in Patients with Locally Advanced or Metastatic Solid Tumors and in Combination with Endocrine Therapy in Patients with Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.